February 1, 2017
Akers Biosciences expects 66% revenue increase, falls short in China
Akers Biosciences, a developer of rapid health information technologies, expects the total revenue for the 2016 year to be about…
Pharmaceuticals, Biotechnology and Life Sciences
Category: North America
January 31, 2017
Trump pushes drugmakers for lower prices, more U.S. production
U.S. President Donald Trump in a meeting on Tuesday with pharmaceutical executives called on them to manufacture more of their drugs in the United States and cut prices, while vowing to speed approval of new medicines and ease regulation.
January 31, 2017
Trump wants drugmakers to produce in US, calls for quicker drug approval
The newly appointed president of the United States of America, Donald Trump said that he wants pharmaceutical companies to manufacture their products in America, during the meeting he held with leaders of some of the major drugmakers.
January 31, 2017
Trump to meet Novartis CEO, other pharma bosses on Tuesday
U.S. President Donald Trump, who has accused drugmakers of “getting away with murder” on prices, will meet executives from the pharmaceutical industry at the White House on Tuesday.
January 31, 2017
Lilly’s Q4 net income up 61%
Driven by new products, including Trulicity, Cyramza, Jardiance and Taltz, Lilly’s volume-driven significant growth in 2016.
January 31, 2017
FDA grants ODD to GenSight’s retinitis pigmentosa drug
GenSight Biologics, a biopharma company that discovers and develops innovative gene therapies for neurodegenerative retinal diseases and diseases of the central nervous system, today announced that the U.S. Food and Drug Administration (FDA) has granted orphan drug designation (ODD) to the Company’s product candidate GS030 for the treatment of retinitis pigmentosa.
January 31, 2017
Teva launches two asthma products in 2017 to compete with GSK
Teva’s two asthma treatments for patients older than 12 has been approved by the US Food and Drug Administration (FDA).
January 31, 2017
US Court rules in Mylan’s favor, another decision against Teva
Israel’s largest drugmaker, Teva, has came up short yet again against a US courts regarding patent infringement cases.
January 30, 2017
Another USA laswusit against Teva, Aralez charges for 4 patent infringements
Aralez Pharmaceuticals will press charges against Teva in the USA for infringing four patents.
January 30, 2017
Realm Therapeutics asks FDA’s approval for its first IND for atopic dermatitis treatment
Realm Therapeutics has submitted its first investigational new drug (IND) application to the U.S. Food and Drug Administration (FDA) for PR022, as a novel treatment for atopic dermatitis (AD).